Clinical Research Directory
Browse clinical research sites, groups, and studies.
Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
Sponsor: Amsterdam UMC, location VUmc
Summary
The goal of this single-center observational cohort study, based on a registry combining retrospectively and prospectively collected data, is to investigate the short- and long-term effects of irreversible electroporation (IRE) in men and women over the age of 18 who receive IRE for recurrence of pelvic tumors not suitable for other local treatment options such as surgery, thermal ablation, and radiotherapy. The main question it aims to answer is whether IRE is safe in this population, and secondarily, whether it is effective in controlling local tumor recurrence.
Official title: Irreversible Electroporation (IRE) of Recurrent Pelvic Tumors: the PELFIRE Study.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
27
Start Date
2025-04-18
Completion Date
2028-07
Last Updated
2026-08-28
Healthy Volunteers
No
Conditions
Interventions
Irreversible electroporation
Irreversible electroporation
Locations (1)
Amsterdam UMC
Amsterdam, North Holland, Netherlands